Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Medical Devices | Videos
Drug Research
Drug Discovery & Development
Return to: PBR Home | Drug Research | Drug Discovery & Development | News
Search Refinements

Drug Discovery & Development News

View news from other Pharmaceutical sectors:
91-105 of 4387 results
Researchers engineer antimicrobial peptide to kill bacteria
By PBR Staff Writer
A team of researchers has developed a new weapon intended for taking down bacteria that are becoming increasingly resistant to existing antibiotics.
Drug Research > Drug Discovery & Development > News
Turnstone Biologics raises $41.4m to advance cancer immunotherapy
By PBR Staff Writer
Canada-based oncolytic viral immunotherapies developer Turnstone Biologics has raised $41.4m in a Series B venture financing.
Drug Research > Drug Discovery & Development > News
Astellas to acquire Ganymed Pharmaceuticals in EUR1.28bn deal
By PBR Staff Writer
Japan’s Astellas Pharma has agreed to acquire Germany-based Ganymed Pharmaceuticals in a deal that could potentially reach €1.28bn.
Drug Research > Drug Discovery & Development > News
Allergan exercises option to buy Motus Therapeutics
By PBR Staff Writer
Allergan has exercised its option to acquire Motus Therapeutics, a biopharmaceutical firm engaged in the development of peptide therapeutics to treat gastrointestinal (GI) diseases.
Drug Research > Drug Discovery & Development > News
Inositec secures $1.42m financing to advance new class of inositol hexaphosphate-based drug candidates
Inositec, which is engaged in the development of life-saving small molecule drugs based on inositol hexaphosphate (IP6), has closed a CHF1.4m ($1.42m) seed financing.
Drug Research > Drug Discovery & Development > News
GSK partners with Fimbrion to develop UTI drug
By PBR Staff Writer
GlaxoSmithKline (GSK) has partnered with US life sciences firm Fimbrion Therapeutics for the development of a small molecule drug to treat prevent urinary tract infections (UTIs).
Drug Research > Drug Discovery & Development > News
Debiopharm reaches key development milestones for Staphylococcus-selective antibiotic Debio 1450
Debiopharm International has announced various significant achievements in the development of its new antibiotic Debio 1450, selectively active on staphylococcal species including hard-to-treat methicillin-resistant Staphylococcus aureus (MRSA).
Drug Research > Drug Discovery & Development > News
NBE Therapeutics, Sotio partner to develop next-generation antibody-drug conjugates
NBE Therapeutics and Sotio have partnered to develop next-generation antibody-drug conjugates (ADCs) for improved cancer therapy.
Drug Research > Drug Discovery & Development > News
Redx Pharma identifies drug development candidate for leukaemia program
Redx Pharma has identified a drug development candidate for its reversible Bruton’s Tyrosine Kinase (BTK) inhibitor program.
Drug Research > Drug Discovery & Development > News
Sun Pharma, ICGEB partner to develop dengue vaccine
Drugmaker Sun Pharmaceutical Industries has partnered with the International Centre for Genetic Engineering and Biotechnology (ICGEB) to develop a new dengue vaccine.
Drug Research > Drug Discovery & Development > News
Domain Therapeutics creates new company to stop Parkinson’s disease progression
France-based biopharmaceutical firm Domain Therapeutics has established a new company, Mavalon Therapeutics, dedicated to develop a drug candidate to stop the progression of Parkinson’s disease.
Drug Research > Drug Discovery & Development > News
Antegrin and Cascadia merge to form Indalo Therapeutics
Antegrin Therapeutics and Cascadia Therapeutics have established Indalo Therapeutics, a biotechnology company dedicated to developing novel therapies to treat fibrotic diseases.
Drug Research > Drug Discovery & Development > News
Sofinnova closes latest venture capital fund at $650m
Biotech-focused investment company Sofinnova has closed Sofinnova Venture Partners X at its hard cap of $650m.
Drug Research > Drug Discovery & Development > News
TransThera raises $10m financing to develop Novel NCE Drugs
Biotech startup TransThera Biosciences has raised Round A Financing close to $10m from a group of investors, led by Morningside Ventures.
Drug Research > Drug Discovery & Development > News
AMAG Pharmaceuticals achieves key milestones in next generation development programs
AMAG Pharmaceuticals has achieved two key milestones in its next generation development programs for Makena and Feraheme.
Drug Research > Drug Discovery & Development > News
91-105 of 4387 results